India's CDSCO Takes Action Against Entod Pharmaceuticals for Misleading Eye Drops Promotion

Wednesday, 11 September 2024, 08:15

India's Central Drugs Standard Control Organization (CDSCO) has suspended Entod Pharmaceuticals' eye drops, PresVu, over unauthorized promotion. Concerns arose regarding claims that PresVu reduces the need for reading glasses. This suspension highlights the importance of regulatory compliance in the pharmaceutical industry.
Cnbctv18
India's CDSCO Takes Action Against Entod Pharmaceuticals for Misleading Eye Drops Promotion

Regulatory Suspension of Eye Drops

The Central Drugs Standard Control Organization (CDSCO) has taken a significant step by suspending the manufacturing and marketing license of Entod Pharmaceuticals for its eye drops, PresVu, due to unauthorized promotion.

Misleading Claims and Regulatory Concerns

On September 10, the CDSCO issued an order stating, “PresVu by Entod Pharmaceuticals Ltd has not been approved to make any claims that it is designed to reduce the need for reading glasses.” The approval was strictly for treating presbyopia in adults, and Entod's claims regarding enhanced near vision were unauthorized.

  • The CDSCO's order emphasized that false claims misleadingly portrayed PresVu as an over-the-counter drug rather than a prescription-only medication.
  • Concerns were raised over the promotion including misleading statements in press and social media, reflecting misuse of granted permissions.
  • Safety concerns prompted the regulator to challenge Entod's claims, leading to the suspension until satisfactory explanations were provided.

Clinical Trials and Prescription Only Status

Entod highlighted that their approval by DCGI was based on valid controlled clinical trials involving 234 patients, showing safety and efficacy in improving near vision.


Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the latest and most reliable health updates. Stay informed and enhance your wellness knowledge effortlessly.

Subscribe